American Chamber of Commerce in Korea
|
DATE & TIME
|
Thursday, September 3, 2026
8:30 am – 1:00 pm
|
|
|
VENUE
|
|
Ruby Hall (Young Bin Gwan 1 Fl.), The Hotel Shilla
|
|
|
TOPIC
|
|
From Reform to Execution: Building a Predictable Healthcare Innovation Ecosystem
|
|
DESCRIPTION
|
|
As Korea continues to expand its role as a global leader in healthcare innovation,
the importance of a predictable, globally
aligned, and innovation-friendly regulatory environment has
become increasingly critical. Amid continuing discussions on regulatory
competitiveness and non-tariff barriers in the context of U.S.-Korea economic
cooperation, the successful implementation of healthcare reforms will play an
important role in shaping Korea’s attractiveness as a destination for global
investment and innovation.
Building on last year’s dialogue on the healthcare priorities of the new administration, the AMCHAM Healthcare Innovation Seminar 2026 will focus on the implementation of key healthcare reforms and the steps needed to further align Korea’s healthcare policies with global standards. The Seminar will bring together government officials, industry leaders, and policy experts from Korea and the United States to discuss the future direction of healthcare innovation and policy in Korea.
Particular attention will be given to the implementation of the MOHW’s pharmaceutical pricing reforms announced in late 2025, including efforts to improve patient access and strengthen value recognition for innovative medicines. Discussions will also explore broader healthcare innovation priorities, including regulatory pathways for advanced healthcare technologies, digital health solutions, and public-private collaboration needed to strengthen Korea’s long-term healthcare competitiveness.
Through keynote presentations and panel discussions, the Seminar aims to foster practical dialogue between policymakers and industry leaders on policy priorities needed to strengthen innovation, patient access, and Korea’s global healthcare competitiveness.
|
|
COST
|
• Member Companies: KRW 143,000 per admission
• Non-Member Companies: KRW 198,000 per admission
|
|
|
|
8:30am – 8:55am
|
Registration & VIP Session
|
|
8:55am – 9:00am
|
Group Photo Session
|
|
|
|
9:00am – 9:05am
|
|
|
|
James Kim
Chairman & CEO
AMCHAM Korea
|
|
|
|
9:05am – 9:10am
|
|
|
|
TBD
|
|
|
|
9:10am – 9:15am
|
|
Congratulatory Remarks II
|
|
|
The Hon. James Heller
Deputy Chief of Mission
U.S. Embassy Seoul
|
|
|
|
Session 1 - Pricing Reform for Innovative Medicines
|
|
|
9:15am – 9:30am
|
|
Keynote Presentation: Advancing Health Insurance Coverage: Policy Priorities Following Korea's Pharmaceutical Pricing Reform
|
|
|
Cho Won Jun
Policy Committee
Democratic Party of Korea
|
|
|
|
9:30am – 9:40am
|
|
Implementing the Pricing Reform: Industry Proposals for a Sustainable Innovation Ecosystem
|
|
|
Seiya Komatsu
Lilly Korea
|
|
|
|
9:40am – 10:20am
|
|
Panel Discussion I: Implementing Healthcare Reform – Balancing Innovation, Access, and Sustainability
|
|
|
Moderator
Youngjoo Song
Senior Advisor
Bae, Kim & Lee LLC
|
|
|
|
Cho Won Jun
Policy Committee
Democratic Party of Korea
|
|
|
|
TBD
Director-General, Health Insurance Policy
Ministry of Health and Welfare
|
|
|
Christian Rodseth
North Asia Area Managing Director
Johnson & Johnson Innovative Medicine
|
|
|
|
TBD
BMS Korea
|
|
|
|
Session II: Vaccines for a Healthier Future
|
|
|
10:20am – 10:25am
|
|
Special Address: The Future Direction of Korea's National Immunization Policy
|
|
|
Jung Tong Ryoung
Director-General, Department of Healthcare Safety and Immunization
Korea Disease Control and Prevention Agency (KDCA)
|
|
|
|
10:25am – 10:35am
|
|
Advancing Life-course Immunization: A Strategic Investment in Public Health (TBD)
|
|
|
|
TBD
Pfizer Korea
|
|
|
|
10:35am – 10:45am
|
|
Unlocking the Future of Vaccines Through mRNA Innovation (TBD)
|
|
|
|
TBD
Moderna
|
|
|
|
10:45am – 11:15am
|
|
Panel Discussion II: Strengthening Korea's Vaccine Ecosystem – Access, Innovation, and Preparedness
|
|
|
|
Moderator
TBD
|
|
|
|
TBD
Director, Department of Healthcare Safety and Immunization
Korea Disease Control and Prevention Agency (KDCA)
|
|
|
Albert Kim
Managing Director
MSD Korea
|
|
|
|
TBD
Pfizer Korea
|
|
|
|
TBD
Moderna
|
|
|
|
11:15am – 11:25am
|
Coffee Break
|
|
Session III: AI & Policy Shaping for the Future of Healthcare
|
|
|
11:20am – 11:30am
|
|
AI as a Catalyst for Healthcare Transformation – Driving Better Policy and Better Patient Outcomes (TBD)
|
|
|
|
TBD
BMS Korea
|
|
|
|
11:30am – 11:40am
|
|
From Innovation to Implementation: Policy Pathways for Precision Healthcare
|
|
|
Dr. Karthik G M
Director, Regulatory Affairs & Product
Guardant Health AMEA(Asia Pac, Middle East & Africa)
|
|
|
|
11:45am – 12:15pm
|
|
Panel Discussion III: From Innovation to Access – Aligning Policy with the Future of Healthcare
|
|
|
|
Moderator
TBD
|
|
|
|
TBD
Regulatory Reconciliation Committee
|
|
|
Divya D. Mehta
Vice President
Guardant Health AMEA(Asia Pac, Middle East & Africa)
|
|
|
Michael Titus
Chief Operating Officer
Eversight
|
|
|
|
12:15pm – 1:00pm
|
Closing & Lunch
|
|
RSVP BY
|
Tuesday, September 1, 2026
* Registration must be completed in advance.
* Free cancelations will be accepted only until September 1 (12pm noon).
|
|
|
|
50F, Three IFC, 10, Gukjegeumyung-ro, Yeongdeungpo-gu, Seoul, Korea
© American Chamber of Commerce in Korea. All Rights Reserved.
|
|
|
|
